PortView
Tema Heart & Health (HRTS) ETF Holdings & Analysis
ETFOther
What HRTS does
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| ELI LILLY & CO | 11.10% | |
| UNITEDHEALTH GROUP INC | 5.11% | |
| THERMO FISHER SCIENTIFIC INC | 4.96% | |
| NOVO NORDISK A/S | 4.78% | |
| MERCK & CO INC | 4.36% | |
| JOHNSON & JOHNSON | 3.87% | |
| REVOLUTION MEDICINES INC | 3.74% | |
| ROCHE HOLDING AG | 3.71% | |
| CYTOKINETICS INC | 3.54% | |
| GILEAD SCIENCES INC | 3.19% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 78.55% |
| Denmark | 5.22% |
| Switzerland | 6.65% |
| United Kingdom | 2.89% |
| Ireland | 2.15% |
| Israel | 1.07% |
| Japan | 2.07% |
| Canada | 0.89% |
| Other | 0.51% |
PortView Portfolio Insights
PortView analyzes how HRTS fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze HRTS in PortView →Related securities
Related stocks
Frequently asked questions
- What does HRTS track?
- HRTS is the Tema Heart & Health ETF, a Other ETF.
- What is the expense ratio of HRTS?
- Expense ratio data for HRTS is shown on the page when available from our data provider.
- What are the largest holdings in HRTS?
- Top holdings include LLY, UNH, TMO, NOVO-B.CO, MRK.
- How can PortView analyze HRTS overlap with other ETFs?
- PortView computes the holdings overlap between HRTS and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.